FS Development Corp. II (FSII)
| Market Cap | 216.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 21.75M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 21 |
| Last Price | $9.95 |
| Previous Close | $9.95 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 9.95 |
| Day's Range | 9.93 - 9.95 |
| Day's Volume | 918 |
| 52-Week Range | 9.89 - 11.17 |
SPAC-mania is in full swing, and the healthcare sector is starting to pop with new offerings.
SAN FRANCISCO--(BUSINESS WIRE)-- #lifesciences--FS Development Corp. II announced today that it priced its initial public offering of 17,500,000 shares of Class A common stock at $10.00 per share.
FS Development II, the second blank check company formed by Foresite Capital targeting a healthcare business, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.
FS Development Corp. II has filed to go public with an IPO on the NASDAQ.
About FSII
FS Development II is a newly organized blank check company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology and life science infrastructure sector. We were co-founded by Foresite Capital Management, LLC, an investment firm with approximately $3.5 billion in assets under management as of Dec... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Feb 17, 2021 |
| CEO Jim Tananbaum | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol FSII |